Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.nebraska.edu

Clinical Trials

Fatigue in Breast Cancer: A Behavioral Sleep Intervention

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Behavioral: Individual Sleep Promotion Plan
Behavioral: Healthy Eating Control

First Posted Date: 2007-12-13

Last Posted Date: 2023-08-31

Lead Sponsor: University of Nebraska

Target Recruit Count: 220

Registration Number: NCT00572416

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

VELCADE®-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma, or Mantle Cell Lymphoma

Phase 1

Completed

Conditions: Non-hodgkin's Lymphoma
Mantle Cell Lymphoma

Interventions: Drug: Bortezomib
Drug: BEAM (carmustine (BCNU), etoposide, cytarabine, melphalan)

First Posted Date: 2007-12-12

Last Posted Date: 2023-09-28

Lead Sponsor: University of Nebraska

Target Recruit Count: 42

Registration Number: NCT00571493

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Pilot Comparison of Standard Antiviral Therapy With and Without 12 Weeks of Betaine in Genotype 1 Naive Patients

Not Applicable

Withdrawn

Conditions: Chronic Hepatitis C

Interventions: Drug: Peginterferon alpha-2a and ribavirin
Drug: Peginterferon alpha-2a , ribavirin and betaine

First Posted Date: 2007-12-12

Last Posted Date: 2023-08-15

Lead Sponsor: University of Nebraska

Registration Number: NCT00571714

Rituxan and BEAM With Autologous Peripheral Blood Progenitor Transplant for Indolent Lymphoma

Phase 1

Completed

Conditions: Lymphoma

Interventions: Drug: Rituxan
Drug: BEAM
Procedure: Autologous stem cell transplant

First Posted Date: 2007-12-12

Last Posted Date: 2023-09-07

Lead Sponsor: University of Nebraska

Target Recruit Count: 32

Registration Number: NCT00572013

Locations: 🇺🇸
University of Nebraska Medical Center, Section of Oncology/Hematology, Omaha, Nebraska, United States

Evaluation of Airway Gene Expression in COPD and Controlled Populations

Terminated

Conditions: COPD

First Posted Date: 2007-12-12

Last Posted Date: 2023-12-04

Lead Sponsor: University of Nebraska

Target Recruit Count: 42

Registration Number: NCT00571792

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

The Prospective Evaluation of Pancreatic Function in Pancreas Transplant Recipients

Not Applicable

Completed

Conditions: Transplant
Diabetes

Interventions: Procedure: Oral glucose tolerance test
Procedure: IV Glucose Tolerance Test

First Posted Date: 2007-12-12

Last Posted Date: 2023-10-10

Lead Sponsor: University of Nebraska

Target Recruit Count: 31

Registration Number: NCT00571818

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Bupropion in the Treatment of Methamphetamine Dependence

Not Applicable

Completed

Conditions: Methamphetamine Use Disorder

Interventions: Drug: bupropion SR

First Posted Date: 2007-12-12

Last Posted Date: 2023-10-10

Lead Sponsor: University of Nebraska

Target Recruit Count: 40

Registration Number: NCT00572234

Locations: 🇺🇸
Catholic Charities Campus for Hope, Omaha, Nebraska, United States
🇺🇸
Veterans Affairs Medical Center, Omaha, Omaha, Nebraska, United States

Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant

Phase 2

Completed

Conditions: Peripheral T-cell Lymphoma
Acute Myelogenous Leukemia
Chronic Lymphocytic Leukemia
Myelodysplastic Syndromes
Chronic Myelogenous Leukemia
Non-Hodgkins Lymphoma
Hodgkins Disease
Acute Lymphocytic Leukemia
Multiple Myeloma

Interventions: Drug: Pentostatin
Radiation: Total-body irradiation (TBI)
Drug: Cyclosporine A (CsA)
Drug: Mycophenolate Mofetil (MMF)
Drug: G-CSF

First Posted Date: 2007-12-12

Last Posted Date: 2023-10-24

Lead Sponsor: University of Nebraska

Target Recruit Count: 76

Registration Number: NCT00571662

Locations: 🇺🇸
University of Nebraska Medical Center, Section of Oncology/Hematology, Omaha, Nebraska, United States

Effect of Central Corneal Thickness On IOP Using Various Tonometers

Completed

Conditions: Intraocular Pressure

Interventions: Device: Tonometer

First Posted Date: 2007-12-11

Last Posted Date: 2023-09-05

Lead Sponsor: University of Nebraska

Target Recruit Count: 166

Registration Number: NCT00570791

Locations: 🇺🇸
University of Nebraska Medical Center, Department of Ophthalmolgy and Visual Sciences, Omaha, Nebraska, United States
🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer

Completed

Conditions: Breast Cancer

First Posted Date: 2007-12-07

Last Posted Date: 2023-09-01

Lead Sponsor: University of Nebraska

Target Recruit Count: 27

Registration Number: NCT00569543

Locations: 🇺🇸
Mayo Clinic Cancer Center, Rochester, Minnesota, United States
🇺🇸
Eppley Cancer Center at University of Nebraska Medical Center, Omaha, Nebraska, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy